CanadaBis Capital (CANB) AI Stock Analysis

• Market Cap: C$1.38M
• Dividend Yield: N/A
• Average Volume (3M): 63.89K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.95
• Revenue Growth: -5.87%
• EPS Growth: -239.53%
• Country: CA
• Employees: N/A
• Sector: Services
• Sector Strength: N/A
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): N/A
• Shares Outstanding: 138,256,380
• 10 Day Avg. Volume: 172,725
• 30 Day Avg. Volume: 63,891
• PEG Ratio: 0.03
• Price to Book (P/B): 0.94
• Price to Sales (P/S): 0.37
• P/FCF Ratio: -1.85
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: C$0.01 ▼(-50.00% Downside)
• Action: Reiterated Date: 04/09/26
• Date: Action: Reiterated 04/09/26

The score is mainly weighed down by weak financial performance—especially negative and inconsistent cash flow alongside deteriorating profitability—and is reinforced by bearish technicals with the price below key moving averages and negative MACD. Valuation provides limited offset because the negative P/E reflects losses and there is no dividend support.

Positive Factors

Vertically integrated model

A vertically integrated structure gives durable control over unit costs across cultivation, processing and distribution, supporting margin resilience and operational scalability. Over months this reduces reliance on third-party supply, improving gross-margin durability and strategic pricing flexibility.

Negative Factors

Negative operating and free cash flow

Recurring negative operating and free cash flow across recent years indicates inconsistent cash conversion and elevated funding needs. Over a 2–6 month horizon this raises liquidity and refinancing risk, limiting ability to invest in growth or absorb further margin pressure without external capital.

CanadaBis Capital Business Overview & Revenue Model

Company Description

CanadaBis Capital Inc. engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through three segments: Cultivation and Wholesale, Retail, and Extraction and Tolling. The Cultivation and Wholesale se...

Read more

CanadaBis Capital Inc. engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through three segments: Cultivation and Wholesale, Retail, and Extraction and Tolling. The Cultivation and Wholesale se...

How the Company Makes Money

CanadaBis Capital generates revenue primarily through the sale of cannabis products, including dried flower, pre-rolls, vape cartridges, and concentrates, to both wholesalers and end customers in the Canadian recreational cannabis market. Its vert...

Read more

CanadaBis Capital generates revenue primarily through the sale of cannabis products, including dried flower, pre-rolls, vape cartridges, and concentrates, to both wholesalers and end customers in the Canadian recreational cannabis market. Its vert...

CanadaBis Capital Financial Statement Overview

Breakdown	Oct 2025	Oct 2024	Oct 2023	Oct 2022	Oct 2021
Income Statement
Total Revenue	16.90M	17.95M	22.22M	11.67M	6.87M
Gross Profit	6.98M	8.82M	11.78M	5.57M	2.52M
EBITDA	800.05K	2.09M	5.68M	1.57M	-1.81M
Net Income	-835.20K	600.28K	4.44M	608.33K	-2.68M
Balance Sheet
Total Assets	24.54M	24.55M	22.96M	15.48M	13.28M
Cash, Cash Equivalents and Short-Term Investments	831.06K	1.68M	3.23M	144.88K	849.50K
Total Debt	7.75M	6.44M	7.31M	7.82M	8.44M
Total Liabilities	17.83M	16.45M	15.62M	12.84M	11.46M
Stockholders Equity	6.62M	8.00M	7.25M	2.54M	1.73M
Cash Flow
Free Cash Flow	-3.37M	-594.48K	4.57M	-292.54K	-1.96M
Operating Cash Flow	-3.20M	-256.31K	5.55M	-82.77K	-1.81M
Investing Cash Flow	-169.65K	-328.33K	-965.82K	-209.77K	122.77K
Financing Cash Flow	2.52M	-962.02K	-1.50M	-412.09K	2.37M

CanadaBis Capital Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.02
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CANB, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.03, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 10.57 is Positive, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CANB.

CanadaBis Capital Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	55 Neutral	$13.29B	17.42	10.03%	0.93%	7.13%	-12.93%
CDVA	43 Neutral	C$3.84M	-6.37	50.26%	―	1.60%	-213.10%
CANB	41 Neutral	C$1.38M	-10.76	-11.42%	―	-5.87%	-239.53%
CVGR	41 Neutral	C$1.83M	-1.55	57.31%	―	―	64.22%
AYUR	40 Underperform	C$1.95M	-1.54	-271.33%	―	15.95%	-1.81%

CanadaBis Capital Corporate Events